Colin Reisner

Colin Reisner

Chief Executive Officer bij Pearl Therapeutics, Inc.

Health Technology
Consumer Services
Commercial Services

Profiel

Currently, Colin Reisner holds the position of Chief Executive Officer at Pearl Therapeutics, Inc. He is also Member of American Thoracic Society, Inc. He previously held the position of Head-Clinical Respiratory at AstraZeneca Plc, Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Principal at Boehringer Ingelheim Corp., Assistant Consulting Professor at Duke University and Assistant Consulting Professor at Yale University.
Colin Reisner received an undergraduate degree from the University of the Witwatersrand.

Actieve functies van Colin Reisner

BedrijvenFunctieBegin
Chief Executive Officer 01-10-2007
Corporate Officer/Principal -
Alle actieve functies van Colin Reisner

Eerdere bekende functies van Colin Reisner

BedrijvenFunctieEinde
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Yale University Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Colin Reisner in detail bekijken

Opleiding van Colin Reisner

University of the Witwatersrand Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Colin Reisner in detail bekijken

Connecties

37

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
ASTRAZENECA PLC

Health Technology

Bedrijven in privébezit5

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Colin Reisner